Pharmaceutical
Latest News
FDA suspends license for Valneva’s chikungunya shot
The agency said it had become aware of more reports of serious adverse events, leading center director Vinay Prasad to conclude the vaccine is no long...
Royalty Pharma buys BeOne stake in Amgen lung cancer drug sales
An $885M deal with BeOne Medicine gives the pharma financier rights to a revenue stream from global sales of Imdelltra, which is sold by Amgen.
Fertile ground
Top-rated pharmacies in northern Virginia for personalised fertility care Top-rated pharmacies in northern Virginia for personalised fertility care
<a href="https://www.fiercepharma.com/marketing/serena-williams-gets-ro-boat-discussing-her-glp-1-use-celebrity-ambassador" hreflang="en">Serena Williams gets in the Ro boat, discussing her GLP-1 use as a celebrity ambassador</a>
Serena Williams has a new doubles partner. The 23-time Grand Slam tennis champion is working with Ro, speaking out about how she used the direct-to-pa...
<a href="https://www.fiercepharma.com/pharma/jj-2b-fujifilm-deal-drug-recalls-3-indian-firms-remegen-santen-eye-med-pact" hreflang="en">Fierce Pharma Asia—J&J's $2B Fujifilm deal; Drug recalls for 3 Indian firms; RemeGen, Santen's eye med pact</a>
Johnson & Johnson is spending part of its big U.S. investment at a Fujifilm site. Three Indian drugmakers issued U.S. drug recalls in recent weeks due...
<a href="https://www.fiercepharma.com/pharma/growth-returns-big-pharma-q2" hreflang="en">Big Pharma bounces back in Q2</a>
U.S. pharma bounced back in Q2, and in this episode of "The Top Line," Fierce Pharma's Eric Sagonowsky and Kevin Dunleavy break down the numbers, comp...
<a href="https://www.fiercepharma.com/manufacturing/novo-plant-acquired-catalent-buyout-faces-renewed-fda-scrutiny-form-483-stat" hreflang="en">Novo plant acquired in Catalent buyout faces renewed FDA scrutiny with Form 483: STAT</a>
Despite boasting a new owner, the Indiana manufacturing plant that Novo Nordisk picked up as part of its parent company's Catalent buyout last year co...
<a href="https://www.fiercepharma.com/pharma/uk-pharma-drug-price-talks-break-down-industry-fails-lower-discount-rate" hreflang="en">UK pharma drug price talks break down as industry fails to lower discount rate</a>
Talks between the U.K. government and the biopharma industry have broken down over efforts to lower rebate rates under a national drug cost-containmen...
<a href="https://www.fiercepharma.com/pharma/bavarian-nordic-ceo-says-buyout-needed-vaccine-specialist-reach-it-potential" hreflang="en">Bavarian Nordic CEO says buyout needed for vaccine specialist to reach its potential</a>
On a day when Bavarian Nordic reported booming sales and adjusted its 2025 guidance positively, its CEO said that a private equity buyout of the Danis...
FDA cancels adcomm on Biohaven drug; Catalent lays off staff
Analysts found the agency's decision to cancel the meeting encouraging. Elsewhere, the Novo Holdings-owned CDMO cut about 350 staff in Maryland.
FDA suspends license for Valneva’s chikungunya shot
Royalty Pharma buys BeOne stake in Amgen lung cancer drug sales
Fertile ground
<a href="https://www.fiercepharma.com/pharma/growth-returns-big-pharma-q2" hreflang="en">Big Pharma bounces back in Q2</a>
FDA cancels adcomm on Biohaven drug; Catalent lays off staff
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago